CN Patent

CN101454002A — 用于治疗前列腺癌和与雄激素受体相关的疾病的雄激素受体调节剂

Assigned to University of California San Diego UCSD · Expires 2009-06-10 · 17y expired

What this patent protects

用于预防或治疗过度增生疾病或病症的乙内酰脲化合物。

USPTO Abstract

用于预防或治疗过度增生疾病或病症的乙内酰脲化合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101454002A
Jurisdiction
CN
Classification
—
Expires
2009-06-10
Drug substance claim
No
Drug product claim
No
Assignee
University of California San Diego UCSD
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.